Everett Harris & CO Bristol Myers Squibb CO Transaction History

Everett Harris & CO

$7.77 Billion
Q2 2024

A detailed history of Everett Harris & CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Everett Harris & CO holds 12,770 shares of BMY stock, worth $689,069. This represents 0.01% of its overall portfolio holdings.

Number of Shares

12,770

Previous 12,770 -0.0%

Holding current value

$689,069

Previous $692,000 23.41%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	SELL	$47.98 - $54.4 $21,351 - $24,208	-445 Reduced 3.37%	12,770 $692,000
Q4 2023 Jan 18, 2024	SELL	$48.48 - $57.85 $163,232 - $194,780	-3,367 Reduced 20.31%	13,215 $678,000
Q3 2023 Oct 23, 2023	SELL	$57.89 - $64.73 $18,756 - $20,972	-324 Reduced 1.92%	16,582 $962,000
Q2 2023 Jul 26, 2023	SELL	$63.71 - $70.74 $32,683 - $36,289	-513 Reduced 2.95%	16,906 $1.08 Million
Q2 2022 Jul 22, 2022	BUY	$72.62 - $79.98 $62,017 - $68,302	854 Added 5.16%	17,419 $1.34 Million
Q1 2022 Apr 22, 2022	BUY	$61.48 - $73.72 $24,284 - $29,119	395 Added 2.44%	16,565 $1.21 Million
Q4 2021 Feb 02, 2022	SELL	$53.63 - $62.52 $24,133 - $28,134	-450 Reduced 2.71%	16,170 $1.01 Million
Q3 2021 Nov 03, 2021	BUY	$59.17 - $69.31 $26,626 - $31,189	450 Added 2.78%	16,620 $983,000
Q4 2020 Feb 04, 2021	SELL	$57.74 - $65.43 $17,322 - $19,629	-300 Reduced 1.82%	16,170 $1 Million
Q2 2020 Jul 29, 2020	BUY	$54.82 - $64.09 $10,964 - $12,818	200 Added 1.23%	16,470 $968,000
Q1 2020 Apr 29, 2020	BUY	$46.4 - $67.43 $134,560 - $195,547	2,900 Added 21.69%	16,270 $907,000
Q4 2019 Jan 27, 2020	BUY	$49.21 - $64.19 $657,937 - $858,220	13,370 New	13,370 $858,000
Q3 2019 Nov 06, 2019	SELL	$42.77 - $50.71 $361,406 - $428,499	-8,450 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$44.62 - $49.34 $42,299 - $46,774	-948 Reduced 10.09%	8,450 $383,000
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $33,114 - $37,350	-600 Reduced 6.0%	9,398 $583,000
Q2 2018 Jul 27, 2018	BUY	$50.53 - $62.98 $30,318 - $37,788	600 Added 6.38%	9,998 $553,000
Q3 2017 Oct 11, 2017	BUY	$55.23 - $63.74 $519,051 - $599,028	9,398	9,398 $599,000

Others Institutions Holding BMY

# of Institutions

2,407

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $115B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Everett Harris & CO , based on Form 13F filings with the SEC.

News

Stay updated on Everett Harris & CO with notifications on news.

Account

Everett Harris & CO Bristol Myers Squibb CO Transaction History